PROS AND CONS OF A HIGH-FLOW NASAL OXYGEN THERAPY IN PATIENTS WITH RESPIRATORY FAILURE
DOI:
https://doi.org/10.31379/2411.2616.15.1.1Keywords:
respiratory failure; respiratory therapy; high-flow oxygen therapy; non-invasive lung ventilation; intensive careAbstract
Objectives: to evaluate clinical efficiency of high-flow nasal oxygen therapy (HFNOT) in patients with respiratory failure. Methods: Prospective two-stage randomized clinical trial including 100 patients with I-II grade respiratory failure and community-acquired right-sided lower lobe pneumonia and posterior mediastinal gastro-esophogoplasty (GEP) with thoracoabdominal access and intrapleural anastomosis. At first stage HFNOT and non-invasive mask ventilation (NIMV) were compared for patients with communityacquired pneumonia. At second stage the use of HFNOT and standard respiratory therapy (RT) were evaluated for patients with (GEP). Following characteristics were analyzed: oxygenation index (PaO2/FiО2); arterial saturation (SaO2), chest X-ray and CT-scan; ventilation time; ventilation tolerability (scale from 1 to 10); conversion to mechanical ventilation frequency; ICU-stay. Results: Patients with community-acquired pneumonia better tolerated HFNOT (8±1 pts vs. 4±2 pts NIMV) with significantly longer ventilation time (up to 20 hrs. vs 3) and with comparable oxygenation index and arterial saturation. ICU-stay and conversion to mechanical ventilation were also comparable. At second stage patients after GEP had comparable oxygenation parameters, but they had lesser conversion to mechanical ventilation rate (15% vs. 22,5%), atelectasis rate (50 vs против 62,5%) and consequently shorter ICU-stay (12±4 vs. 18±3). Conclusion: HFNOT use in patients with respiratory failure shows clinical efficacy, is more tolerable by patients, but does not exclude other respiratory therapy methods.
References
Masclans, J.R., Roca, O. High-flow oxygen therapy in acute respiratory failure. / J.R. Masclans, O. Roca // Clin Pulm Med. – 2012. – Vol. 19. – P. 127-130.
Research in high flow therapy: mechanisms of action. / K. Dysart [et al.] // Respir Med. – 2009. – Vol. 103. – P. 1400- 1405. http://dx.doi.org/10.1016/j.rmed.2009.04.007 | Medline
Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. / A. Corley [et al.] // Br J Anaesth. – 2011. – Vol. 107. – P. 998-1004. http://dx.doi.org/10.1093/bja/aer265 | Medline
Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. / B. Sztrymf [et al.] // J Crit Care. – 2012. – Vol. 27. – P. 324. http://dx.doi.org/10.1016/j.jcrc.2011.07.075 | Medline
Dewan, N.A., Bell, C.W. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea. A study comparing the transtracheal catheter and nasal prongs. / N.A. Dewan, C.W. Bell // Chest. – 1994. – Vol. 105. – P. 1061-1065.
The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. / W. Chatila [et al.] // Chest. – 2004. – Vol. 126. – P. 1108-1115. http://dx.doi.org/10.1378/chest.126.4.1108 | Medline
Ricard, J.D., Boyer, A. Humidification during oxygen therapy and non-invasive ventilation: do we need some and how much? / J.D. Ricard, A. Boyer // Intensive Care Med. – 2009. – Vol. 35. – P. 963-965. http://dx.doi.org/10.1007/s00134-009-1457-9 | Medline
Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. / B. Sztrymf [et al.] // Intensive Care Med. – 2011. – Vol. 37. – P. 1780-1786. http://dx.doi.org/10.1007/s00134-011-2354-6 | Medline
Parke, R., McGuinness, S., Eccleston, M. Nasal high-flow therapy delivers low level positive airway pressure. / R. Parke, S. McGuinness, M. Eccleston // Br J Anaesth. – 2009. – Vol. 103. – P. 886-890. http://dx.doi.org/10.1093/bja/aep280 | Medline
A multiple-center survey on the use in clinical practice of noninvasive ventilation as a firstline intervention for acute respiratory distress syndrome. / M. Antonelli [et al.] // Crit Care Med. – 2007. – Vol. 35. – P.18-25.
Esophageal perforation associated with noninvasive ventilation: a case report. / A. Van de Louw [et al.] // Chest. – 2002. – Vol. 122. – P. 1857-8.
Dysart, K. et al. Research in high flow therapy: mechanisms of action. / K. Dysart [et al.] // Respir Med. – 2009. – Vol. 103. – P. 1400.
Parke, R., McGunness, S., Eccleston, M. Nasal high-flow therapy delivers low level positive airway pressure. / R. Parke, S. McGunness, M. Eccleston // Br J Anaesth. – 2009. – Vol. 103. – P. 886–90.
High-flow oxygen therapy in acute respiratory failure. / O. Roca [et al.] // Respir Care. – 2010. – Vol. 55. – P. 408.
High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. / R. Tiruvoipati [et al.] // J Crit Care. – 2010. – Vol. 25. – P. 463.
Chertoff, J. High-Flow Oxygen, Positive End-Expiratory Pressure, and the Berlin Definition of Acute Respiratory Distress Syndrome: Are They Mutually Exclusive? / J. Chertoff // Am J Respir Crit Care Med. – 2017. – Vol. 196. – P. 396.
Applications of nasal high-flow oxygen therapy in critically ill adult patients. / J. Porhomayon [et al.] // Lung. – 2016. – Vol. 194(5). – P. 705-14.
Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. / B.J. Kang [et al.] // Intensive Care Med. – 2015. – Vol. 41. – P. 623–632.
Brochard, L., Slutsky, A., Pesenti, A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. / L. Brochard, A. Slutsky, A. Pesenti // Am J Respir Crit Care Med. – 2017. – Vol. 195. – P. 438.
Hegde, S., Prodhan, P. Serious air leak syndrome complicating highflow nasal cannula therapy: a report of 3 cases. / S. Hegde, P. Prodhan // Pediatrics. – 2013. – Vol. 131(3). – P. 939–944.
